Patient eligibility
The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with odevixibat under the National Health Act 1953, section 85 for patients with PFIC.
Patients must be eligible for the PBS and meet the relevant restriction criteria.
The Schedule of Pharmaceutical Benefits on the PBS website outlines the restrictions for prescribing odevixibat.
Treatment specifics
To be eligible for PBS-subsidised treatment with odevixibat, patients diagnosed under the age of 18 must be treated by either a:
- gastroenterologist experienced in the management of PFIC
- hepatologist experienced in the management of PFIC.
Patients diagnosed over the age of 18 must be treated by a specialist hepatologist experienced in the management of PFIC.
Authority applications
Applying for initial treatment
Please note: You don’t need to complete this application in writing when you request PBS authority online.
Applications for initial authority approval to prescribe PBS-subsidised odevixibat to treat PFIC can be made:
- using the Online PBS Authorities system
- in writing and using HPOS Form upload
- in writing and mailed to PBS Complex Drugs Programs.
All written applications must include:
- details of the proposed prescription or prescriptions
- the completed progressive familial intrahepatic cholestasis - odevixibat - initial authority application form
- relevant attachments.
Applying for continuing, recommencement or dose modification
Please note: You’ll get an immediate assessment when you request PBS authorities online.
Applications for continuing, recommencement or dose modification authority approval to prescribe PBS-subsidised odevixibat to treat PFIC can be made:
- in real time using the Online PBS Authorities system
- by calling the PBS Complex Drugs Programs enquiry line.
More information
Call the PBS Complex Drugs Programs enquiry line for more information.